Lymphotoxin-β-deficient mice show defective antiviral immunity

Virology

Volumn 260, Issue 1, 1999, Pages 136-147

  Berger, Dietmar P ^a   Naniche, Denise ^a   Crowley, Mary T ^a   Koni, Pandelakis A ^b   Flavell, Richard A ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell surface molecules; CTL; Dendritic cells; Lymphoid organization

Indexed keywords

LYMPHOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; IMMUNE DEFICIENCY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033587636     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9811     Document Type: Article

References (39)

1. Ahmed R., Salmi A., Butler L. D., Chiller J. M., Oldstone M. B. A. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 60:1984;521-540.
2. Alimzhanov M. B., Kuprash D. V., Kosco-Vilbois M. H., Luz A., Turetskaya R. L., Tarakhovsky A., Rajewski K., Nedospasov S. A., Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;9302-9307.
3. Banks T. A., Rouse B. T., Kerley M. K., Blair P. J., Godfrey V. L., Kuklin N. A., Bouley D. M., Thomas J., Kanangat S., Mucenski M. L. Lymphotoxin-α-deficient mice: Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1995;1685-1693.
4. Borrow P., Evans C. F., Oldstone M. B. A. Virus-induced immunosuppression: Immune system-mediated destruction of virus infected dendritic cells results in generalized immune suppression. J. Virol. 69:1995;1059-1070.
5. + CTL response. J. Exp. Med. 183:1996;2129-2142.
6. Browning J. L., Dougas I., Ngam-ek A., Bourdon P. R., Ehrenfels B. N., Miatkowski K., Zafari M., Yampaglia A. M., Lawton P., Meier W., Benjamin C. P., Hession C. Characterization of surface lymphotoxin forms. J. Immunol. 154:1995;33-46.
7. Buchmeier M. J., Oldstone M. B. A. Virus-induced immune complex disease: Identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. J. Immunol. 120:1978;1297-1304.
8. Byrne J. A., Oldstone M. B. A. Biology of cloned cytotoxic T lymphocytes specific for LCMV: Clearance of virus in vivo. J. Virol. 51:1984;682-686.
9. Cousens L. P., Orange J. S., Biron C. A. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J. Immunol. 155:1995;5690-5699.
10. Crowe P. D., VanArsdale T. L., Walter B. N., Ware C. F., Hession C., Ehrenfels B., Browning J. L., Din W. S., Goodwin R. G., Smith C. A. A lymphotoxin-β-specific receptor. Science. 264:1994;707-710.
11. Crowley M. T., Inaba K., Witmer-Pack M. D., Gezelter S., Steinman R. M. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods. 133:1990;55-66.
12. De Togni P., Goellner J., Ruddle N. H., Streeter P. R., Fick A., Mariathasan S., Smith S. C., Carlson R., Shormick L. P., Strauss-Schoenenberger J., Russell J. H., Karr R., Chaplin D. H. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:1994;703-707.
13. Dutko F. J., Oldstone M. B. A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1983;1689-1698.
14. Eloranta M.-L., Sandberg K., Alm G. V. The interferon-a/β responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand. J. Immunol. 43:1996;355-360.
15. Eugster H. P., Müller M., Karrer U., Car B. D., Schnyder B., Eng V. M., Woerly G., Le Hir M., di Padova F., Aguet M., Zinkernagel R., Bluethmann H., Ryffel B. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int. Immunol. 8:1996;23-36.
16. Fu Y. X., Molina H., Matsumoto M., Huang G., Min J., Chaplin D. D. Lymphotoxin-alpha supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:1997;2111-2120.
17. Fütterer A., Mink K., Luz A., Kosco-Vilbois M. H., Pfeffer K. The lymphotoxin β-receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:1998;59-70.
18. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1993;1742-1745.
19. Joly E., Mucke L., Oldstone M. B. A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253:1991;1283-1285.
20. Karrer U., Althage A., Odermatt B., Roberts C. W. M., Korsmeyer S. J., Miyawaki S., Hengartner H., Zinkernagel R. M. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoblastic (aly/aly) and spleenless (Hox11-/-) mutant mice. J. Exp. Med. 185:1997;2157-2170.
21. Koni P. A., Flavell R. A. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: Genetic evidence of synergism with lymphotoxin β J. Exp. Med. 187:1998;1977-1983.
22. Koni P. A., Sacca R., Lawton P., Browning J. L., Ruddle N. H., Flavell R. A. Distinct roles in lymphoid organogenesis for lymphotoxins a and β revealed in lymphotoxin β-deficient mice. Immunity. 6:1997;491-500.
23. Le Hir M., Bluethmann H., Kosco-Vilbois M. H., Di Padova F., Moore M., Ryffel B., Eugster H. P. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signalling. J. Exp. Med. 183:1996;2367-2372.
24. Matsumoto M., Lo S. F., Carruthers C. J. L., Min J., Mariathasan S., Huang G., Plas D. R., Martin S. M., Geha R. S., Nahm M. H., Chaplin D. H. Affinity maturation without germinal centres in lymphotoxin-a-deficient mice. Nature. 382:1996;462-466.
25. Mauri D. N., Ebner R., Montgomery R. I., Kochel K. D., Cheung T. C., Yu G. L., Ruben S., Murphy M., Eisenberg R. J., Cohen G. H., Spear P. G., Ware C. F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:1998;21-30.
26. McDonald H. R., Cerottini J. C., Ryser J. E., Maryanski J. L., Taswell C., Widmer M., Brunner K. T. Quantitation and cloning of CTL and their precursors. Immunol. Rev. 51:1980;93-123.
27. Moskophidis D., Cobbold S. P., Waldmann H., Lehmann-Grube F. Mechanism of recovery from acute virus infection: Treatment of lymphocytic choriomeningitis virus infected mice with monoclonal antibodies reveals that Lyt2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1987;1867-1874.
28. Muller M., Eugster H. P., Le Hir M., Shakhov A., Di Padova F., Maurer C., Quesniaux V. F., Ryffel B. Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation. Mol. Med. 2:1996;247-255.
29. Oldstone M. B. A., Salvato M., Tishon A., Lewicki H. Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. Virology. 164:1988;507-516.
30. Orange J. S., Biron C. A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. J. Immunol. 156:1996;1138-1142.
31. Oxenius A., Karrer U., Zinkernagel R. M., Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:1999;965-973.
32. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF-alpha deficient mice: A critical requirement for TNF-alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1996;1397-1411.
33. Rennert P. D., James D., Mackay F., Browning J. L., Hochman P. S. Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity. 9:1998;71-79.
34. Rothe J., Mackay F., H. B., Zinkernagel R., Lesslauer W. Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR-1deficient fibroblasts in vitro. Circ. Shock. 44:1994;51-56.
35. Salvato M. S., Shimomaye E., Southern P., Oldstone M. B. A. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, clone 13 (CTL-). Virology. 164:1988;57-62.
36. Seiler P., Aichele P., Odermatt B., Hentgartner H., Zinkernagel R., Schwendener R. A. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 27:1997;2626-2633.
37. Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell. 76:1994;959-962.
38. Van den Broek M. F., Müller U., Huang S., Aguet M., Zinkernagel R. M. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:1995;4792-4796.
39. Ware C. F., VanArsdale T. L., Crowe P. D., Browning J. L. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:1995;175-218.